Showing 20 of 46 recruiting trials for “moderate-hemophilia-b”
RecruitingNCT07414511 ↗
Hemophilia A Research Program
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.
RecruitingNCT06352216 ↗
Prevalence of Synovitis in Patients With Haemophilia A
👨⚕️ Andreas C Strauss, PD Dr. med., University Hospital, Bonn📍 1 site📅 Started Apr 2024View details ↗
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
👨⚕️ Shveta Gupta, MD, Arnold Palmer Hospital for Children📍 18 sites📅 Started Nov 2023View details ↗
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
👨⚕️ Lei Zhang, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Nov 2023View details ↗
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Enrolling by InvitationNCT05962398 ↗
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
👨⚕️ Arina V Zinkina-Orikhan, MD, Director of Clinical Development Department, BIOCAD📍 17 sites📅 Started May 2023View details ↗
RecruitingNCT05802836 ↗
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Embolization in Hereditary Coagulopathies
👨⚕️ Fabiane E FArias, PT, IOT-HC-FMUSP (Orthopedics Institute - General Hospital- School of Medicine - University of Sao Paulo📍 1 site📅 Started Jan 2023View details ↗
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.
👨⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Sep 2022View details ↗
Pharmacokinetic-guided Dosing of Emicizumab
Hemlibra in Mild Hemophilia A
👨⚕️ Amy D Shapiro, MD, Indiana Hemophilia &Thrombosis Center, Inc.📍 1 site📅 Started Jul 2022View details ↗
A Study of FVIII Gene Therapy for Hemophilia A
👨⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05202951 ↗
Chronic Pain and Hemophilia
👨⚕️ Aurélien LEBRETON, University Hospital, Clermont-Ferrand📍 10 sites📅 Started Feb 2022View details ↗
Trial of an Exercise Intervention for Children With Haemophilia
👨⚕️ David Stephensen, PhD, East Kent Hospitals University NHS Foundation Trust📍 1 site📅 Started May 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →